Exact Mass: 277.27693500000004

Exact Mass Matches: 277.27693500000004

Found 15 metabolites which its exact mass value is equals to given mass value 277.27693500000004, within given mass tolerance error 3.2E-7 dalton. Try search metabolite list with more accurate mass tolerance error 6.4E-8 dalton.

Perhexiline

(-)-2-(2,2-Dicyclohexylethyl)piperidine

C19H35N (277.27693500000004)


Perhexiline is only found in individuals that have used or taken this drug. It is a coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis. [PubChem]Perhexiline binds to the mitochondrial enzyme carnitine palmitoyltransferase (CPT)-1 and CPT-2. It acts by shifting myocardial substrate utilisation from long chain fatty acids to carbohydrates through inhibition of CPT-1 and, to a lesser extent, CPT-2, resulting in increased glucose and lactate utilization. This results in increased ATP production for the same O2 consumption as before and consequently increases myocardial efficiency. C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C - Cardiovascular system > C08 - Calcium channel blockers > C08E - Non-selective calcium channel blockers D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   
   

2-(5-Hexenyl)-3,4-dihydro-5-nonyl-2H-pyrrole

2-(5-Hexenyl)-3,4-dihydro-5-nonyl-2H-pyrrole

C19H35N (277.27693500000004)


   
   

2-Hex-5-enyl-5-non-8-enyl-pyrrolidine

2-Hex-5-enyl-5-non-8-enyl-pyrrolidine

C19H35N (277.27693500000004)


   

(2R,5R)-2-(pent-4-en-1-yl)-5-pentyldecahydroquinoline

(2R,5R)-2-(pent-4-en-1-yl)-5-pentyldecahydroquinoline

C19H35N (277.27693500000004)


   

(5R,6R,8R,8aR)-6,8-dimethyl-5-(non-8-en-1-yl)octahydroindolizine

(5R,6R,8R,8aR)-6,8-dimethyl-5-(non-8-en-1-yl)octahydroindolizine

C19H35N (277.27693500000004)


   

1-methyl-4-(non-8-en-1-yl)octahydro-2H-quinolizine

1-methyl-4-(non-8-en-1-yl)octahydro-2H-quinolizine

C19H35N (277.27693500000004)


   

(3R,5S)-5-methyl-3-(non-8-en-1-yl)octahydro-1H-pyrrolo[1,2-a]azepine

(3R,5S)-5-methyl-3-(non-8-en-1-yl)octahydro-1H-pyrrolo[1,2-a]azepine

C19H35N (277.27693500000004)


   

PERHEXILINE

PERHEXILINE

C19H35N (277.27693500000004)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C - Cardiovascular system > C08 - Calcium channel blockers > C08E - Non-selective calcium channel blockers D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

(3r,5r,9ar)-5-methyl-3-(non-8-en-1-yl)-octahydro-1h-pyrrolo[1,2-a]azepine

(3r,5r,9ar)-5-methyl-3-(non-8-en-1-yl)-octahydro-1h-pyrrolo[1,2-a]azepine

C19H35N (277.27693500000004)


   

2-(hex-1-en-1-yl)-5-nonyl-4,5-dihydro-1h-pyrrole

2-(hex-1-en-1-yl)-5-nonyl-4,5-dihydro-1h-pyrrole

C19H35N (277.27693500000004)


   

5-methyl-3-(non-8-en-1-yl)-octahydro-1h-pyrrolo[1,2-a]azepine

5-methyl-3-(non-8-en-1-yl)-octahydro-1h-pyrrolo[1,2-a]azepine

C19H35N (277.27693500000004)


   

2-(hex-1-en-1-yl)-5-nonylidenepyrrolidine

2-(hex-1-en-1-yl)-5-nonylidenepyrrolidine

C19H35N (277.27693500000004)


   

(2s,5s)-2-(hex-5-en-1-yl)-5-(non-8-en-1-yl)pyrrolidine

(2s,5s)-2-(hex-5-en-1-yl)-5-(non-8-en-1-yl)pyrrolidine

C19H35N (277.27693500000004)